Polysaccharides

Compound Class	Polysaccharides — high-molecular-weight carbohydrate polymers; an umbrella class, not a single chemistry
Representative Members	β-Glucans (fungal), astragalus polysaccharides, PSK/PSP (protein-bound), acidic heteropolysaccharides
Botanical / Fungal Sources	Astragalus membranaceus, Tremella fuciformis, Trametes versicolor, Ganoderma lucidum, Cordyceps
Plant Part(s)	Root (astragalus); fruiting body and mycelium (fungi)
Typical Standardisation	Total polysaccharides by phenol-sulfuric or gravimetric method; 30–70% commercial range. This assay is notoriously non-specific
Primary Applications	Immunomodulatory formulation; adjunct oncology support (PSK, in Japan); prebiotic and skin-hydration applications
Claim Strength (Overview)	Moderate for specific characterised polysaccharides (PSK); Emerging for "total polysaccharides" as a specification, which conveys little
Buy from Herbuno	Polysaccharides 70% Powder (Huang Qi Extract) | Standardized Astragalus membranaceus → Polysaccharides 30% Powder (Turkey Tail Extract) | Standardized Trametes versicolor →

Name origin: Polysaccharide is a purely structural designation — "many sugars" — and that breadth is precisely the problem this page must confront. Starch, cellulose, chitin, inulin, and the immunomodulatory β-glucans of medicinal fungi are all polysaccharides, and they share essentially nothing pharmacologically. A "total polysaccharides 70%" specification is therefore one of the least informative figures in the botanical ingredient trade, and this monograph exists partly to say so plainly. Traditional use: No traditional system identified polysaccharides as such — they were unknown until modern carbohydrate chemistry. What is traditional is the use of the source materials: Astragalus membranaceus (huang qi) as a premier qi-tonifying and defensive-energy herb in Traditional Chinese Medicine; Tremella fuciformis (snow mushroom) as a beauty and lung-moistening food; and Trametes versicolor (yun zhi, turkey tail) for longevity. Research trajectory: The decisive event in this field was Japanese: the immunomodulatory activity of Trametes versicolor polysaccharide peptides was noticed in 1965 after an observed cancer remission, leading to the isolation of Krestin (PSK) in 1971 and its subsequent approval and routine use in Japan as an adjunctive cancer immunotherapy — making PSK one of very few fungal polysaccharides with genuine regulated-market clinical standing rather than supplement-category positioning. Commercial source: Standardized extracts from multiple botanicals and fungi. Buyers should treat the source organism and the structural characterisation as the meaningful specifications, and the total-polysaccharide percentage as a rough completeness check at best.

---

Evidence for Polysaccharides Applications

The best-evidenced polysaccharide in this class is PSK, and its standing is genuinely unusual. Polysaccharide K — PSK or Krestin — is a protein-bound polysaccharide extracted from the mycelia of Coriolus versicolor strain CM-101, with a mean molecular weight of about 94 kDa, composed of a glucan with β1–4 bonds in the main chain and β1–3 and β1–6 bonds in the side chain, the latter bound to a protein moiety through O- or N-glycoside bonds (Sakamoto 2017). Note how precisely that is specified — strain, molecular weight, glycosidic linkage pattern, protein content. That is what a meaningful polysaccharide specification looks like, and it is the standard against which "total polysaccharides 70%" should be judged. Claim strength: Moderate.

PSK has genuine clinical evidence rather than merely preclinical promise. It has been used in Japan for more than thirty years as an adjunctive immunotherapy across several cancer types, with controlled human trials documenting extended survival times in breast, colorectal, and other gastrointestinal cancers; structurally it is roughly 62% polysaccharide and 38% protein, and it has been shown to act as a TLR2 agonist mediating tumour-growth inhibition via CD8 T-cell and NK-cell stimulation (Standish 2008). This is adjunctive use alongside conventional oncology in a regulated market, and must never be presented to consumers as a cancer treatment or a supplement claim. Claim strength: Moderate (as regulated adjuvant; not transferable to supplement claims).

The central scientific fact about this class is that structure determines function, and molecular weight, branching pattern, glycosidic linkage, and monosaccharide composition all matter. The immunomodulatory β-glucans act largely through pattern-recognition receptors — dectin-1, TLR2, complement receptor 3 — which recognise specific structural motifs, principally β-1,3 backbones with β-1,6 branching. A polysaccharide lacking those motifs is simply not the same ingredient, however high its assay. This is why source organism and structural characterisation, not percentage, are the specifications that carry information. Claim strength: High (established structural pharmacology).

The standardisation problem is severe and worth stating without euphemism. The common phenol-sulfuric and gravimetric assays measure total carbohydrate, and will happily count starch, maltodextrin, and free sugars alongside the bioactive polysaccharides. This makes the assay trivially inflatable — a documented adulteration route in the medicinal mushroom trade is the addition of starch or grain-based mycelium substrate, which raises the "polysaccharide" figure while diluting the β-glucan content. A high total-polysaccharide number, absent a specific β-glucan assay, is therefore not merely uninformative but potentially a red flag. Claim strength: High (documented trade issue).

The source materials in this class are chemically diverse and are not substitutable for one another. Astragalus polysaccharides are plant-derived heteropolysaccharides, structurally unrelated to fungal β-glucans and acting through different pathways. Tremella polysaccharides are acidic glucuronoxylomannans, valued primarily for their exceptional water-holding capacity and used commercially as a cosmetic humectant rather than an immunomodulator. Trametes delivers protein-bound β-glucans. A formulator specifying "polysaccharides" without naming the organism has specified essentially nothing. Claim strength: High (compositional fact).

---

Dosage & Formulator Specification

Herbuno carries polysaccharide-standardized extracts across multiple source organisms: Astragalus membranaceus (70% and 50%), Tremella fuciformis snow mushroom (70% and 40%), Trametes versicolor turkey tail (30%), Ganoderma lucidum, and Tinospora cordifolia (40%). Source-specific polysaccharide pages for Lycium barbarum (LBP) and Aloe barbadensis are documented separately in this index, as are β-glucans as a structural subclass.

Dosing cannot be given meaningfully for "polysaccharides" as a category, and a supplier who offers one is not being straight with you. PSK, the best-characterised member, has been used in Japanese adjuvant oncology at defined pharmaceutical doses under medical supervision — a context entirely outside supplement formulation. For supplement applications, dose must be set against the specific source organism and, ideally, against a β-glucan assay rather than total polysaccharide. Formulators should identify the specific polysaccharide their claim depends on before setting a serving size.

Analytical verification is where this class demands the most discipline. Do not accept a total-polysaccharide figure alone: request a specific β-glucan assay (enzymatic, e.g. Megazyme-type, which distinguishes β-glucan from α-glucan/starch), the α-glucan figure alongside it (a high α-glucan reading indicates starch or grain substrate), the source organism and part (fruiting body versus mycelium-on-grain), and where possible molecular-weight distribution. For fungal material, fruiting-body versus mycelium origin is a material and frequently obscured distinction.

Botanical and fungal polysaccharides from established food species are generally well tolerated, with gastrointestinal effects (bloating, loose stools) from the fermentable fraction being the most common complaint. Two cautions. Because several of these polysaccharides are genuinely immunostimulatory, caution is warranted for individuals with autoimmune conditions or on immunosuppressive therapy — a stimulated immune response is not universally desirable, a point made at greater length on the Bitter Diterpenoids page in this index. Second, PSK’s oncology standing is as a regulated adjuvant used alongside conventional treatment under medical supervision; presenting it, or any mushroom polysaccharide, as a cancer treatment in a consumer context would be both false and dangerous.

---

Frequently Asked Questions — Polysaccharides

What does "total polysaccharides 70%" actually tell you?
Very little, and that is the honest answer. The common phenol-sulfuric and gravimetric assays measure total carbohydrate, counting starch, maltodextrin, and free sugars alongside bioactive polysaccharides. The figure is trivially inflatable — adding grain substrate raises it while diluting the actual beta-glucan. A high number without a specific beta-glucan assay can be a red flag rather than a selling point.

What should I ask for instead?
A specific beta-glucan assay (enzymatic, which distinguishes beta- from alpha-glucan), the alpha-glucan figure alongside it, the source organism and part (fruiting body versus mycelium-on-grain), and ideally molecular weight distribution. Structure determines function in this class — molecular weight, branching, and linkage pattern all matter.

Is PSK evidence transferable to mushroom supplements?
No. PSK is a precisely characterised protein-bound polysaccharide from a specific Trametes strain, used in Japan as a regulated adjunctive immunotherapy alongside conventional cancer treatment under medical supervision. That is an entirely different context from supplement formulation, and its evidence must never be presented as supporting consumer cancer claims.

Are astragalus, tremella, and turkey tail polysaccharides interchangeable?
Not remotely. Astragalus polysaccharides are plant heteropolysaccharides; Tremella yields acidic glucuronoxylomannans valued mainly as a cosmetic humectant; Trametes delivers protein-bound beta-glucans acting through pattern-recognition receptors. Specifying "polysaccharides" without naming the organism specifies essentially nothing.

Related compounds: Beta-Glucans, Lentinan, Astragaloside IV, Inulin

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery